Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors-Reference-Cited by-同舟云学术

Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors

Published:2002-03 Issue:3 Volume:9 Page:228-235
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Abe Tatsuya,Wakimoto Hiroaki,Bookstein Robert,Maneval Daniel C,Chiocca E Antonio,Basilion James P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7700437.pdf

Reference35 articles.

1. Duncan EL, Reddel RR . Genetic changes associated with immortalization. A review Biochemistry (Moscow) 1997 62: 1263–1274

2. Chin L, Pomerantz J, DePinho RA . The INK4a/ARF tumor suppressor: one gene–two products–two pathways Trends Biochem Sci 1998 23: 291–296

3. Carnero A, Hudson JD, Price CM, Beach DH . p16INK4A and p19ARF act in overlapping pathways in cellular immortalization [see comments] Nat Cell Biol 2000 2: 148–155

4. Nielsen LL, Maneval DC . P53 tumor suppressor gene therapy for cancer Cancer Gene Ther 1998 5: 52–63

5. Anderson SC, Johnson DE, Harris MP et al. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus Clin Cancer Res 1998 4: 1649–1659

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art;Frontiers in Oncology;2022-09-23

2. Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics;Cancers;2022-06-16

3. Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles;Journal of Controlled Release;2022-03

4. Superselective intra-arterial cerebral infusion to improve brain tumor drug delivery;Therapeutic Delivery;2022-01

5. A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases;Frontiers in Neuroscience;2021-09-24